Guardant Health, Inc. GH

177.25 0.80 0.45% as of 25 Sep
Market cap
$23.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

192.39% 348.42% 200.62% 171.64%
ROA
(28.33%) (23.79%) (26.58%) (27.95%)
ROIC
(153.52%) (134.56%) (127.36%) (129.70%)
Return on Tangible Assets
(55.65%) (31.80%) (35.35%) (38.40%)
Average Days of Receivables
46.74 51.24 46.43 44.50
Free Cash Flow per Share
(2.10) (1.86) (1.81) (1.81)
Free Cash Flow
(262.23) (233.07) (237.12) (240.72)
Capital Expenditures
(39.33) (48.31) (49.43) (55.54)
Piotroski F-Score
4.00 6.00 6.00 6.00
Other line items
Cash ROIC
(16.63%) (7.09%) (7.74%) (7.94%)
Accounts Receivable Turnover
8.85 7.92 8.55 8.62
Accounts Payable Turnover
18.37 7.51 6.08 5.99
Inventory Turnover
4.02 4.45 4.71 4.37
Average Days of Payables
22.48 56.94 72.22 82.46
Days of Inventory on Hand
100.97 89.81 80.71 92.99
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
39.83% 37.09% 33.95% 31.76%
Selling, General and Administrative Expense of Revenue
72.95% 71.90% 72.38% 73.00%
Share Based Compensation of Revenue
17.66% 16.93% 16.30% 16.17%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.56 0.44 0.43 0.41
Depreciation/Fixed assets
0.27 0.23 0.18 0.16
Capex/Depreciation
(1.18) (1.43) (1.84) (2.19)
Revenue per Share
7.23 7.83 8.23 8.90
Operating CF per Share
(1.79) (1.47) (1.43) (1.39)
Capex per Share
(0.32) (0.39) (0.38) (0.42)
Capex to Sales
0.04 0.05 0.05 0.05
Net Profit Margin
(44.18%) (42.39%) (40.10%) (38.33%)

Fold the line items

Columns are period end dates